A gene expression-based test identifies patients with primary cutaneous melanoma at a lower or higher risk for sentinel lymph ...

DecisionDx-Melanoma continues to demonstrate strong performance in helping physicians make more informed, risk-aligned ...

Pi Network’s update to its node infrastructure, version 0.5.4 of the Pi Desktop application, went live in the early morning ...

Apex Legends just added something mysterious, Heirloom Loot Ticks, also called Node Trackers, and players are starting to ...

The long-running Contagious Interview campaign is now hiding BeaverTail and InvisibleFerret payloads inside JSON storage ...

The SEALSQ Quantum Corridor positions the company at the intersection of semiconductor sovereignty, post-quantum resilience, and the emerging quantum economy, while reinforcing Europe's leadership in ...

Cyklar, created by long-time creator Claudia Sulewski, is all about luxurious bodycare formulas in thoughtfully designed ...

Description: Dive into the epic showdown between two of sci-fi's iconic creatures in "Alien vs Predator." This thrilling video explores the intense battle of wits and survival instincts as deadly ...

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data demonstrating ...

A web of undersea cables connects our lives and our global economy. As U.S. adversaries are accused of sabotage, they're ...

Of patients identified as low risk by combined clinicopathological factors and GEP test, only 7.1 percent were SLN-positive.